Sign in
8-K

Current Report

Dianthus Therapeutics, Inc. /DE/ Filed Acc 0001193125-21-237056

Results of operations · Executive or director change

  • Item 2.02 Results of operations and financial condition
  • Item 5.02 Departure or appointment of directors or officers

From the SEC's structured data for this filing

Loading d206907d8k.htm…